Hospital AI opportunity Target hospital systems and ICU departments with a focus on AI-driven glucose control solutions that reduce patient risk and drive cost savings, highlighting the artificial pancreas concept and its potential to modernize critical care.

Early-stage funding Leverage the recent $200K debt financing as a signal of investor interest and runway; propose pilot programs or proof-of-concept engagements with clinicians to demonstrate value before larger scale investments.

Regulatory path Position for FDA validation partnerships and regulatory consulting as a pathway to market, offering support services or collaboration opportunities with firms experienced in medical device approvals to accelerate commercialization.

Small-team agility Highlight the lean size as an advantage for rapid decision-making; pursue co-development or supplier partnerships to scale manufacturing, integration, and go-to-market activities without heavy overhead.

Tech-stack leverage Emphasize compatibility with cloud-native infrastructure and security controls (Google Cloud, ASP.NET, React) to appeal to IT and procurement in health systems seeking robust, compliant tech partners for clinical devices.